Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Krka, d.d., a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in Slovenia (SI). Established in 1954, the company has grown to become a prominent manufacturer of generic pharmaceuticals, with a strong presence in Europe and beyond. Krka's core business areas include the development, production, and marketing of prescription medicines, over-the-counter products, and animal health products.
Renowned for its commitment to quality and innovation, Krka offers a diverse range of products, including cardiovascular, central nervous system, and anti-infective medications. The company has achieved significant milestones, including numerous awards for its research and development efforts, solidifying its market position as a trusted provider of high-quality pharmaceuticals. With a focus on sustainability and patient-centric solutions, Krka continues to make strides in the global pharmaceutical landscape.
+19 vs industry average
Krka’s score of 61 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Krka, a Slovenian pharmaceutical preparation manufacturer, reported total carbon emissions of approximately 628,355,000 kg CO2e in 2025. This includes 59,917,000 kg CO2e from Scope 1 emissions, 13,616,000 kg CO2e from market-based Scope 2 emissions, and 554,822,000 kg CO2e from Scope 3 emissions.
In 2024, Krka's total carbon emissions were around 598,682,000 kg CO2e, comprising 56,868,000 kg CO2e from Scope 1, 17,133,000 kg CO2e from market-based Scope 2, and 524,681,000 kg CO2e from Scope 3.
Krka has set a near-term target to reduce its total carbon footprint (Scope 1) by 71% by 2030, using 2019 as the baseline year. Additionally, the company aims for a 11,270,000 kg CO2e reduction in total Scope 1 and Scope 2 GHG emissions by 2030, compared to 2023 levels. Krka also has a long-term climate neutrality objective, aiming to decarbonise transport and become carbon neutral in terms of electricity and natural gas supplies by 2050.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more